TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7610761
log Bayes Factor = <0.0001
Chromosome 3   position 188,184,929  (GRCh37) Explore rs7610761 on Ensembl!
Variant rs7610761 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
N02.8 Other
0.065 0.935 0.000
N02 Recurrent and persistent haematuria
0.038 0.962 0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis
0.029 0.971 0.000
N02.2 Diffuse membranous glomerulonephritis
0.029 0.971 0.000
T42.4 Benzodiazepines
0.000 0.972 0.028
R20.2 Paraesthesia of skin
0.028 0.972 0.000
N02.7 Diffuse crescentic glomerulonephritis
0.028 0.972 0.000
N02.6 Dense deposit disease
0.028 0.972 0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis
0.028 0.972 0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis
0.028 0.972 0.000
N02.1 Focal and segmental glomerular lesions
0.027 0.973 0.000
R20 Disturbances of skin sensation
0.027 0.973 0.000
R20.8 Other and unspecified disturbances of skin sensation
0.026 0.974 0.000
N02.0 Minor glomerular abnormality
0.026 0.974 0.000
N02.9 Unspecified
0.025 0.975 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.976 0.024
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.976 0.024
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.976 0.024
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.976 0.024
R20.1 Hypoaesthesia of skin
0.023 0.976 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.977 0.023
K82.4 Cholesterolosis of gallbladder
0.000 0.979 0.021
K82 Other diseases of gallbladder
0.000 0.979 0.021
N00-N08 Glomerular diseases
0.020 0.980 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.980 0.020
T42.1 Iminostilbenes
0.000 0.980 0.020
K82.8 Other specified diseases of gallbladder
0.000 0.981 0.019
R20.0 Anaesthesia of skin
0.019 0.981 0.000
N05 Unspecified nephritic syndrome
0.019 0.981 0.000
K82.9 Disease of gallbladder, unspecified
0.000 0.981 0.019
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.981 0.019
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.981 0.019
T36 Poisoning by systemic antibiotics
0.000 0.982 0.018
R20.3 Hyperaesthesia
0.018 0.982 0.000
K82.2 Perforation of gallbladder
0.000 0.982 0.018
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.982 0.018
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.982 0.018
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.982 0.018
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.983 0.017
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.983 0.017
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.983 0.017
T42.2 Succinimides and oxazolidinediones
0.000 0.983 0.017
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.983 0.017
T43.9 Psychotropic drug, unspecified
0.000 0.983 0.017
T42.3 Barbiturates
0.000 0.983 0.017
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.983 0.017
T50.4 Drugs affecting uric acid metabolism
0.000 0.983 0.017
N05.2 Diffuse membranous glomerulonephritis
0.016 0.984 0.000
T39.1 4-Aminophenol derivatives
0.000 0.984 0.016
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.984 0.016
N03 Chronic nephritic syndrome
0.016 0.984 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.984 0.016
K86.0 Alcohol-induced chronic pancreatitis
0.000 0.984 0.016
N05.9 Unspecified
0.016 0.984 0.000
K86.3 Pseudocyst of pancreas
0.000 0.984 0.016
T42.0 Hydantoin derivatives
0.000 0.984 0.016
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.984 0.016
K86 Other diseases of pancreas
0.000 0.984 0.016
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.985 0.015
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.015 0.985 0.000
T36.0 Penicillins
0.000 0.985 0.015
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.985 0.015
K86.1 Other chronic pancreatitis
0.000 0.985 0.015
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.985 0.015
N07 Hereditary nephropathy, not elsewhere classified
0.015 0.985 0.000
N06 Isolated proteinuria with specified morphological lesion
0.015 0.985 0.000
N01 Rapidly progressive nephritic syndrome
0.015 0.985 0.000
K82.0 Obstruction of gallbladder
0.000 0.985 0.015
N05.1 Focal and segmental glomerular lesions
0.015 0.985 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.985 0.015
N05.7 Diffuse crescentic glomerulonephritis
0.015 0.985 0.000
T50.7 Analeptics and opioid receptor antagonists
0.000 0.985 0.014
T50.5 Appetite depressants
0.000 0.985 0.014
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.985 0.014
T50.1 Loop [high-ceiling] diuretics
0.000 0.985 0.014
T50.0 Mineralocorticoids and their antagonists
0.000 0.985 0.014
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.985 0.014
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.985 0.014
N00 Acute nephritic syndrome
0.014 0.985 0.000
T50.8 Diagnostic agents
0.000 0.986 0.014
T36.3 Macrolides
0.000 0.986 0.014
J43.9 Emphysema, unspecified
0.014 0.986 0.000
N05.6 Dense deposit disease
0.014 0.986 0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.014 0.986 0.000
N05.0 Minor glomerular abnormality
0.014 0.986 0.000
K82.1 Hydrops of gallbladder
0.000 0.986 0.014
N05.8 Other
0.014 0.986 0.000
N03.2 Diffuse membranous glomerulonephritis
0.014 0.986 0.000
T36.4 Tetracyclines
0.000 0.986 0.014
T38.1 Thyroid hormones and substitutes
0.000 0.986 0.014
T40.1 Heroin
0.000 0.986 0.014
L40.9 Psoriasis, unspecified
0.014 0.986 0.000
T43.6 Psychostimulants with abuse potential
0.000 0.986 0.013
T36.9 Systemic antibiotic, unspecified
0.000 0.986 0.013
T36.8 Other systemic antibiotics
0.000 0.986 0.013
T36.7 Antifungal antibiotics, systemically used
0.000 0.986 0.013
T36.6 Rifamycins
0.000 0.986 0.013
T36.5 Aminoglycosides
0.000 0.986 0.013
T36.2 Chloramphenicol group
0.000 0.986 0.013
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.986 0.013
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.013 0.986 0.000
T40.5 Cocaine
0.000 0.987 0.013
T40.2 Other opioids
0.000 0.987 0.013
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.987 0.013
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.987 0.013
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.987 0.013
T47.2 Stimulant laxatives
0.000 0.987 0.013
T40.4 Other synthetic narcotics
0.000 0.987 0.013
T47.4 Other laxatives
0.000 0.987 0.013
T39.4 Antirheumatics, not elsewhere classified
0.000 0.987 0.013
T39.2 Pyrazolone derivatives
0.000 0.987 0.013
T45.5 Anticoagulants
0.000 0.987 0.013
T47.0 Histamine H(2)-receptor antagonists
0.000 0.987 0.013
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.987 0.013
T40.8 Lysergide [LSD]
0.000 0.987 0.013
T40.7 Cannabis (derivatives)
0.000 0.987 0.013
T40.3 Methadone
0.000 0.987 0.013
T40.0 Opium
0.000 0.987 0.013
S32.00 Fracture of lumbar vertebra (closed)
0.013 0.987 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.987 0.013
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.987 0.013
K82.3 Fistula of gallbladder
0.000 0.987 0.013
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.987 0.013
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.987 0.012
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.987 0.012
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.987 0.012
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.987 0.012
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.987 0.012
T44.0 Anticholinesterase agents
0.000 0.987 0.012
N04 Nephrotic syndrome
0.012 0.987 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.987 0.012
N03.8 Other
0.012 0.988 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.988 0.012
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.988 0.012
T47.7 Emetics
0.000 0.988 0.012
T47.5 Digestants
0.000 0.988 0.012
T47.3 Saline and osmotic laxatives
0.000 0.988 0.012
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.988 0.012
T41.5 Therapeutic gases
0.000 0.988 0.012
T41.4 Anaesthetic, unspecified
0.000 0.988 0.012
T41.3 Local anaesthetics
0.000 0.988 0.012
T41.2 Other and unspecified general anaesthetics
0.000 0.988 0.012
T41.1 Intravenous anaesthetics
0.000 0.988 0.012
T41.0 Inhaled anaesthetics
0.000 0.988 0.012
N03.7 Diffuse crescentic glomerulonephritis
0.012 0.988 0.000
N03.6 Dense deposit disease
0.012 0.988 0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis
0.012 0.988 0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis
0.012 0.988 0.000
N03.0 Minor glomerular abnormality
0.012 0.988 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.988 0.012
T45.8 Other primarily systemic and haematological agents
0.000 0.988 0.012
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.988 0.012
T45.6 Fibrinolysis-affecting drugs
0.000 0.988 0.012
T45.3 Enzymes, not elsewhere classified
0.000 0.988 0.012
N03.1 Focal and segmental glomerular lesions
0.012 0.988 0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis
0.012 0.988 0.000
T45.0 Antiallergic and antiemetic drugs
0.000 0.988 0.012
T40.6 Other and unspecified narcotics
0.000 0.988 0.012
T38.9 Other and unspecified hormone antagonists
0.000 0.988 0.011
T38.7 Androgens and anabolic congeners
0.000 0.988 0.011
T38.5 Other oestrogens and progestogens
0.000 0.988 0.011
T38.4 Oral contraceptives
0.000 0.988 0.011
T38.2 Antithyroid drugs
0.000 0.988 0.011
K80-K87 Disorders of gallbladder, biliary tract and pancreas
0.000 0.989 0.011
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.989 0.011
T48.4 Expectorants
0.000 0.989 0.011
T48.3 Antitussives
0.000 0.989 0.011
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.989 0.011
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.989 0.011
T48.0 Oxytocic drugs
0.000 0.989 0.011
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.989 0.011
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.989 0.011
T47.6 Antidiarrhoeal drugs
0.000 0.989 0.011
M20.0 Deformity of finger(s)
0.000 0.989 0.011
N03.9 Unspecified
0.011 0.989 0.000
T38.0 Glucocorticoids and synthetic analogues
0.000 0.989 0.011
T45.4 Iron and its compounds
0.000 0.989 0.011
N01.9 Unspecified
0.011 0.989 0.000
N01.8 Other
0.011 0.989 0.000
N01.7 Diffuse crescentic glomerulonephritis
0.011 0.989 0.000
N01.6 Dense deposit disease
0.011 0.989 0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis
0.011 0.989 0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis
0.011 0.989 0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis
0.011 0.989 0.000
N01.2 Diffuse membranous glomerulonephritis
0.011 0.989 0.000
N01.1 Focal and segmental glomerular lesions
0.011 0.989 0.000
N01.0 Minor glomerular abnormality
0.011 0.989 0.000
N06.9 Unspecified
0.011 0.989 0.000
N06.8 Other
0.011 0.989 0.000
N06.7 Diffuse crescentic glomerulonephritis
0.011 0.989 0.000
N06.6 Dense deposit disease
0.011 0.989 0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis
0.011 0.989 0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis
0.011 0.989 0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis
0.011 0.989 0.000
N06.2 Diffuse membranous glomerulonephritis
0.011 0.989 0.000
N06.1 Focal and segmental glomerular lesions
0.011 0.989 0.000
N06.0 Minor glomerular abnormality
0.011 0.989 0.000
N07.9 Unspecified
0.011 0.989 0.000
N07.8 Other
0.011 0.989 0.000
N07.7 Diffuse crescentic glomerulonephritis
0.011 0.989 0.000
N07.6 Dense deposit disease
0.011 0.989 0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis
0.011 0.989 0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis
0.011 0.989 0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis
0.011 0.989 0.000
N07.2 Diffuse membranous glomerulonephritis
0.011 0.989 0.000
N07.1 Focal and segmental glomerular lesions
0.011 0.989 0.000
N07.0 Minor glomerular abnormality
0.011 0.989 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.989 0.011
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.989 0.011
T37.5 Antiviral drugs
0.000 0.989 0.011
T37.4 Anthelminthics
0.000 0.989 0.011
T37.3 Other antiprotozoal drugs
0.000 0.989 0.011
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.989 0.011
T37.1 Antimycobacterial drugs
0.000 0.989 0.011
T37.0 Sulphonamides
0.000 0.989 0.011
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.989 0.011
C67.9 Bladder, unspecified
0.011 0.989 0.000
T48.5 Anti-common-cold drugs
0.000 0.989 0.010
T49.9 Topical agent, unspecified
0.000 0.989 0.010
T49.8 Other topical agents
0.000 0.989 0.010
T49.7 Dental drugs, topically applied
0.000 0.989 0.010
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.989 0.010
T49.5 Ophthalmological drugs and preparations
0.000 0.989 0.010
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.989 0.010
T49.3 Emollients, demulcents and protectants
0.000 0.989 0.010
T49.2 Local astringents and local detergents
0.000 0.989 0.010
T49.1 Antipruritics
0.000 0.989 0.010
N00.8 Other
0.010 0.989 0.000
N00.7 Diffuse crescentic glomerulonephritis
0.010 0.989 0.000
N00.6 Dense deposit disease
0.010 0.989 0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis
0.010 0.989 0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis
0.010 0.989 0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis
0.010 0.989 0.000
N00.2 Diffuse membranous glomerulonephritis
0.010 0.989 0.000
N00.1 Focal and segmental glomerular lesions
0.010 0.989 0.000
N00.0 Minor glomerular abnormality
0.010 0.989 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.990 0.010
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.990 0.010
K86.8 Other specified diseases of pancreas
0.000 0.990 0.010
N00.9 Unspecified
0.010 0.990 0.000
N08 Glomerular disorders in diseases classified elsewhere
0.010 0.990 0.000
N72 Inflammatory disease of cervix uteri
0.010 0.990 0.000
N04.1 Focal and segmental glomerular lesions
0.010 0.990 0.000
T39.0 Salicylates
0.000 0.990 0.010
T50.6 Antidotes and chelating agents, not elsewhere classified
0.001 0.990 0.009
T45.2 Vitamins, not elsewhere classified
0.000 0.990 0.009
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.990 0.009
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.991 0.009
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.991 0.009
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.991 0.009
T46.7 Peripheral vasodilators
0.000 0.991 0.009
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.991 0.009
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.991 0.009
Z01.5 Diagnostic skin and sensitisation tests
0.009 0.991 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.991 0.009
N04.8 Other
0.009 0.991 0.000
N04.7 Diffuse crescentic glomerulonephritis
0.009 0.991 0.000
N04.6 Dense deposit disease
0.009 0.991 0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis
0.009 0.991 0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis
0.009 0.991 0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis
0.009 0.991 0.000
C67.2 Lateral wall of bladder
0.009 0.991 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.991 0.009
C67.5 Bladder neck
0.009 0.991 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.991 0.009
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.991 0.008
N04.0 Minor glomerular abnormality
0.009 0.991 0.000
C67 Malignant neoplasm of bladder
0.009 0.991 0.000
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue
0.009 0.991 0.000
K86.2 Cyst of pancreas
0.000 0.991 0.009
N04.2 Diffuse membranous glomerulonephritis
0.008 0.991 0.000
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere
0.000 0.992 0.008
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.992 0.008
K81.9 Cholecystitis, unspecified
0.000 0.992 0.008
K85 Acute pancreatitis
0.000 0.992 0.008
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases
0.007 0.992 0.000
C67.0 Trigone of bladder
0.008 0.992 0.000
R23 Other skin changes
0.008 0.992 0.000
K81 Cholecystitis
0.000 0.992 0.008
N08.8 Glomerular disorders in other diseases classified elsewhere
0.007 0.993 0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism
0.007 0.993 0.000
N08.1 Glomerular disorders in neoplastic diseases
0.007 0.993 0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere
0.007 0.993 0.000
K86.9 Disease of pancreas, unspecified
0.000 0.993 0.007
N04.9 Unspecified
0.007 0.993 0.000
T46.1 Calcium-channel blockers
0.000 0.993 0.007
C67.8 Overlapping lesion of bladder
0.007 0.993 0.000
K85.9 Acute pancreatitis, unspecified
0.000 0.993 0.007
R23.2 Flushing
0.007 0.993 0.000
C67.7 Urachus
0.006 0.993 0.000
L40 Psoriasis
0.007 0.993 0.000
R23.3 Spontaneous ecchymoses
0.006 0.993 0.000
R23.0 Cyanosis
0.006 0.993 0.000
R21 Rash and other nonspecific skin eruption
0.006 0.994 0.000
T43.2 Other and unspecified antidepressants
0.000 0.994 0.006
K85.0 Idiopathic acute pancreatitis
0.000 0.994 0.006
L40.0 Psoriasis vulgaris
0.006 0.994 0.000
K87.1 Disorders of pancreas in diseases classified elsewhere
0.000 0.994 0.006
K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere
0.000 0.994 0.006
K85.8 Other acute pancreatitis
0.000 0.994 0.006
K85.3 Drug-induced acute pancreatitis
0.000 0.994 0.006
S32.0 Fracture of lumbar vertebra
0.006 0.994 0.000
R23.1 Pallor
0.006 0.994 0.000
K85.2 Alcohol-induced acute pancreatitis
0.000 0.994 0.006
C67.4 Posterior wall of bladder
0.006 0.994 0.000
J43 Emphysema
0.006 0.994 0.000
N08.5 Glomerular disorders in systemic connective tissue disorders
0.005 0.994 0.000
C67.6 Ureteric orifice
0.005 0.995 0.000
L40.4 Guttate psoriasis
0.005 0.995 0.000
R23.8 Other and unspecified skin changes
0.005 0.995 0.000
N08.3 Glomerular disorders in diabetes mellitus
0.005 0.995 0.000
L40.2 Acrodermatitis continua
0.005 0.995 0.000
L40.5 Arthropathic psoriasis
0.005 0.995 0.000
J43.8 Other emphysema
0.005 0.995 0.000
S32.01 Fracture of lumbar vertebra (open)
0.004 0.995 0.000
C67.3 Anterior wall of bladder
0.004 0.995 0.000
L40.3 Pustulosis palmaris et plantaris
0.004 0.996 0.000
E13.9 Without complications
0.004 0.996 0.000
F32.3 Severe depressive episode with psychotic symptoms
0.000 0.996 0.004
J43.1 Panlobular emphysema
0.004 0.996 0.000
J43.0 MacLeod's syndrome
0.004 0.996 0.000
K81.8 Other cholecystitis
0.000 0.996 0.004
S64.4 Injury of digital nerve of other finger
0.004 0.996 0.000
M54.16 Radiculopathy (Lumbar region)
0.000 0.996 0.004
L40.8 Other psoriasis
0.004 0.996 0.000
G82.5 Tetraplegia, unspecified
0.000 0.996 0.004
S27.30 Other injuries of lung (without open wound into thoracic cavity)
0.000 0.996 0.004
T31.0 Burns involving less than 10% of body surface
0.000 0.996 0.004
O75.8 Other specified complications of labour and delivery
0.004 0.996 0.000
C67.1 Dome of bladder
0.003 0.996 0.000
L40.1 Generalised pustular psoriasis
0.003 0.996 0.000
G82.1 Spastic paraplegia
0.000 0.996 0.004
J43.2 Centrilobular emphysema
0.003 0.996 0.000
K81.0 Acute cholecystitis
0.000 0.996 0.003
S64.3 Injury of digital nerve of thumb
0.003 0.997 0.000
S64.0 Injury of ulnar nerve at wrist and hand level
0.003 0.997 0.000
L05.9 Pilonidal cyst without abscess
0.000 0.997 0.003
V23.4 Driver injured in traffic accident
0.000 0.997 0.003
S64 Injury of nerves at wrist and hand level
0.003 0.997 0.000
M71.26 Synovial cyst of popliteal space [Baker]-Lower Leg
0.003 0.997 0.000
G82 Paraplegia and tetraplegia
0.000 0.997 0.003
Q18.1 Preauricular sinus and cyst
0.003 0.997 0.000
T92.1 Sequelae of fracture of arm
0.000 0.997 0.003
S29.9 Unspecified injury of thorax
0.000 0.997 0.003
H43.1 Vitreous haemorrhage
0.003 0.997 0.000
G37.9 Demyelinating disease of central nervous system, unspecified
0.003 0.997 0.000
R60.0 Localised oedema
0.003 0.997 0.000
Z49.0 Preparatory care for dialysis
0.003 0.997 0.000
O75.0 Maternal distress during labour and delivery
0.003 0.997 0.000
H43.8 Other disorders of vitreous body
0.003 0.997 0.000
S64.7 Injury of multiple nerves at wrist and hand level
0.003 0.997 0.000
Z92.3 Personal history of irradiation
0.003 0.997 0.000
M54.37 Sciatica (Lumbosacral region)
0.003 0.997 0.000
D12.5 Sigmoid colon
0.000 0.997 0.003
G82.4 Spastic tetraplegia
0.000 0.997 0.003
O24.4 Diabetes mellitus arising in pregnancy
0.003 0.997 0.000
M85.00 Fibrous dysplasia (monostotic) (Multiple sites)
0.003 0.997 0.000
K81.1 Chronic cholecystitis
0.000 0.997 0.003
R23.4 Changes in skin texture
0.002 0.997 0.000
S64.9 Injury of unspecified nerve at wrist and hand level
0.003 0.997 0.000
S64.8 Injury of other nerves at wrist and hand level
0.003 0.997 0.000
Z99.2 Dependence on renal dialysis
0.003 0.997 0.000
I49.0 Ventricular fibrillation and flutter
0.003 0.997 0.000
R60.1 Generalised oedema
0.003 0.997 0.000
G82.3 Flaccid tetraplegia
0.000 0.997 0.002
G82.0 Flaccid paraplegia
0.000 0.997 0.002
L28.1 Prurigo nodularis
0.000 0.997 0.003
Q18.0 Sinus, fistula and cyst of branchial cleft
0.003 0.997 0.000
K83 Other diseases of biliary tract
0.000 0.997 0.003
L28.0 Lichen simplex chronicus
0.000 0.997 0.003
R22.1 Localised swelling, mass and lump, neck
0.003 0.997 0.000
R22 Localised swelling, mass and lump of skin and subcutaneous tissue
0.003 0.997 0.000
K04.8 Radicular cyst
0.000 0.997 0.002
S64.2 Injury of radial nerve at wrist and hand level
0.002 0.998 0.000
I45.6 Preexcitation syndrome
0.002 0.998 0.000
G12.2 Motor neuron disease
0.000 0.998 0.002
K85.1 Biliary acute pancreatitis
0.000 0.998 0.002
L40-L45 Papulosquamous disorders
0.002 0.998 0.000
R22.7 Localised swelling, mass and lump, multiple sites
0.002 0.998 0.000
E13 Other specified diabetes mellitus
0.002 0.998 0.000
Q18 Other congenital malformations of face and neck
0.002 0.998 0.000
S27.3 Other injuries of lung
0.000 0.998 0.002
R56.8 Other and unspecified convulsions
0.000 0.998 0.002
E13.3 With ophthalmic complications
0.002 0.998 0.000
K83.4 Spasm of sphincter of Oddi
0.000 0.998 0.002
R60 Oedema, not elsewhere classified
0.002 0.998 0.000
J01.9 Acute sinusitis, unspecified
0.002 0.998 0.000
Q53.1 Undescended testicle, unilateral
0.000 0.998 0.002
K83.2 Perforation of bile duct
0.000 0.998 0.002
L41 Parapsoriasis
0.002 0.998 0.000
B25.9 Cytomegaloviral disease, unspecified
0.000 0.998 0.002
G82.2 Paraplegia, unspecified
0.000 0.998 0.002
K83.5 Biliary cyst
0.000 0.998 0.002
E13.8 With unspecified complications
0.002 0.998 0.000
E13.7 With multiple complications
0.002 0.998 0.000
E13.6 With other specified complications
0.002 0.998 0.000
E13.5 With peripheral circulatory complications
0.002 0.998 0.000
E13.4 With neurological complications
0.002 0.998 0.000
E13.2 With renal complications
0.002 0.998 0.000
E13.1 With ketoacidosis
0.002 0.998 0.000
E13.0 With coma
0.002 0.998 0.000
S64.1 Injury of median nerve at wrist and hand level
0.002 0.998 0.000
L44 Other papulosquamous disorders
0.002 0.998 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.002 0.998 0.000
L28 Lichen simplex chronicus and prurigo
0.000 0.998 0.002
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus
0.000 0.998 0.002
Q18.9 Congenital malformation of face and neck, unspecified
0.002 0.998 0.000
Q18.8 Other specified congenital malformations of face and neck
0.002 0.998 0.000
Q18.7 Microcheilia
0.002 0.998 0.000
Q18.6 Macrocheilia
0.002 0.998 0.000
Q18.5 Microstomia
0.002 0.998 0.000
Q18.4 Macrostomia
0.002 0.998 0.000
Q18.3 Webbing of neck
0.002 0.998 0.000
Q18.2 Other branchial cleft malformations
0.002 0.998 0.000
R22.3 Localised swelling, mass and lump, upper limb
0.002 0.998 0.000
Y04.8 Other specified place
0.000 0.998 0.002
S27.31 Other injuries of lung (with open wound into thoracic cavity)
0.000 0.998 0.002
K83.9 Disease of biliary tract, unspecified
0.000 0.998 0.002
K83.3 Fistula of bile duct
0.000 0.998 0.002
I87.8 Other specified disorders of veins
0.000 0.998 0.002
L43 Lichen planus
0.002 0.998 0.000
K13.7 Other and unspecified lesions of oral mucosa
0.002 0.998 0.000
Q83.8 Other congenital malformations of breast
0.000 0.998 0.002
H43 Disorders of vitreous body
0.002 0.998 0.000
S02.80 Fractures of other skull and facial bones (closed)
0.000 0.998 0.002
L41.1 Pityriasis lichenoides chronica
0.002 0.998 0.000
O75 Other complications of labour and delivery, not elsewhere classified
0.002 0.998 0.000
V23 Motorcycle rider injured in collision with car, pick-up truck or van
0.000 0.998 0.002
Z83.3 Family history of diabetes mellitus
0.002 0.998 0.000
Z84.8 Family history of other specified conditions
0.002 0.998 0.000
L41.9 Parapsoriasis, unspecified
0.002 0.998 0.000
L41.8 Other parapsoriasis
0.002 0.998 0.000
L41.5 Retiform parapsoriasis
0.002 0.998 0.000
L41.4 Large plaque parapsoriasis
0.002 0.998 0.000
L41.3 Small plaque parapsoriasis
0.002 0.998 0.000
L41.2 Lymphomatoid papulosis
0.002 0.998 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.002 0.998 0.000
L43.9 Lichen planus, unspecified
0.002 0.998 0.000
R40.2 Coma, unspecified
0.000 0.998 0.002
O24 Diabetes mellitus in pregnancy
0.002 0.998 0.000
O24.9 Diabetes mellitus in pregnancy, unspecified
0.002 0.998 0.000
T21.3 Burn of third degree of trunk
0.000 0.998 0.002
T31 Burns classified according to extent of body surface involved
0.000 0.998 0.002
L44.9 Papulosquamous disorder, unspecified
0.001 0.998 0.000
L44.8 Other specified papulosquamous disorders
0.001 0.998 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.001 0.998 0.000
L44.3 Lichen ruber moniliformis
0.001 0.998 0.000
L44.2 Lichen striatus
0.001 0.998 0.000
L44.1 Lichen nitidus
0.001 0.998 0.000
L44.0 Pityriasis rubra pilaris
0.001 0.998 0.000
L42 Pityriasis rosea
0.002 0.998 0.000
S29 Other and unspecified injuries of thorax
0.000 0.998 0.002
O71.4 Obstetric high vaginal laceration alone
0.002 0.998 0.000
O75.3 Other infection during labour
0.002 0.998 0.000
R60.9 Oedema, unspecified
0.002 0.998 0.000
L28.2 Other prurigo
0.000 0.998 0.002
O75.9 Complication of labour and delivery, unspecified
0.002 0.998 0.000
N76.4 Abscess of vulva
0.002 0.998 0.000
L43.3 Subacute (active) lichen planus
0.001 0.998 0.000
L43.2 Lichenoid drug reaction
0.001 0.998 0.000
L43.1 Bullous lichen planus
0.001 0.998 0.000
L43.0 Hypertrophic lichen planus
0.001 0.998 0.000
M71.2 Synovial cyst of popliteal space [Baker]
0.002 0.998 0.000
O24.0 Pre-existing diabetes mellitus, insulin-dependent
0.002 0.998 0.000
Q63.0 Accessory kidney
0.000 0.998 0.002
H43.0 Vitreous prolapse
0.001 0.998 0.000
O75.5 Delayed delivery after artificial rupture of membranes
0.002 0.998 0.000
R22.9 Localised swelling, mass and lump, unspecified
0.002 0.998 0.000
O75.4 Other complications of obstetric surgery and procedures
0.001 0.998 0.000
O75.1 Shock during or following labour and delivery
0.001 0.998 0.000
I83.0 Varicose veins of lower extremities with ulcer
0.002 0.998 0.000
V23.9 Unspecified motorcycle rider injured in traffic accident
0.000 0.998 0.001
V23.3 Person injured while boarding or alighting
0.000 0.998 0.001
V23.2 Unspecified motorcycle rider injured in nontraffic accident
0.000 0.998 0.001
V23.1 Passenger injured in nontraffic accident
0.000 0.998 0.001
V23.0 Driver injured in nontraffic accident
0.000 0.998 0.001
Y04.2 School, other institution and public administrative area
0.000 0.998 0.002
M24.41 Recurrent dislocation and subluxation of joint (Shoulder region)
0.002 0.998 0.000
M70.56 Other bursitis of knee-Lower Leg
0.002 0.998 0.000
J30.1 Allergic rhinitis due to pollen
0.002 0.998 0.000
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified
0.000 0.998 0.002
O24.3 Pre-existing diabetes mellitus, unspecified
0.001 0.998 0.000
O24.2 Pre-existing malnutrition-related diabetes mellitus
0.001 0.998 0.000
O24.1 Pre-existing diabetes mellitus, noninsulin-dependent
0.001 0.998 0.000
O35.8 Maternal care for other (suspected) foetal abnormality and damage
0.000 0.998 0.002
O04.9 Complete or unspecified, without complication
0.000 0.998 0.002
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)
0.000 0.998 0.001
T31.9 Burns involving 90% or more of body surface
0.000 0.998 0.001
T31.8 Burns involving 80-89% of body surface
0.000 0.998 0.001
T31.7 Burns involving 70-79% of body surface
0.000 0.998 0.001
T31.6 Burns involving 60-69% of body surface
0.000 0.998 0.001
T31.5 Burns involving 50-59% of body surface
0.000 0.998 0.001
T31.4 Burns involving 40-49% of body surface
0.000 0.998 0.001
T31.3 Burns involving 30-39% of body surface
0.000 0.998 0.001
T31.2 Burns involving 20-29% of body surface
0.000 0.998 0.001
V23.5 Passenger injured in traffic accident
0.000 0.998 0.001
G37.8 Other specified demyelinating diseases of central nervous system
0.001 0.998 0.000
I45.2 Bifascicular block
0.002 0.998 0.000
S29.7 Multiple injuries of thorax
0.000 0.998 0.001
S29.0 Injury of muscle and tendon at thorax level
0.000 0.998 0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.